BioSpace News Archive

Kidneys eliminates waste from the body, regulates blood pressure, allows hormones to create red blood cells, and ensures right amount of mineral content in the body.

Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays.

The healthcare facilities require reliable, coordinated, and easy transportation of their patients.

Increase in number of promotional activities carried out by key players has played a major role in the growth of the brain health supplements market.

Rise in anaphylaxiscases and increases in R&D activities by key players in the market are anticipated todrive the market.

Increase in geriatric population, growing prevalence of neurological and epidemic disorders, and introduction of novel and innovative products for nerve repair and regeneration are likely to drive the market growth.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QIAreach® SARS CoV-2 Antigen Test, which is designed for environments that require a high volume of fast and accurate test results.

DBV Technologies, a clinical-stage biopharmaceutical company, issued the Half-Year report on its liquidity contract with ODDO BHF.

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders, liver disease and certain cancers, today announced that it intends to offer shares of its common stock in an underwritten public offering.

Botulinum toxin, known to the mankind as one of the most poisonous biological substances, is a neurotoxin produced by the Clostridium botulinum bacteria.